DrugPatentWatch Database Preview

Details for Patent: 6,878,721

« Back to Dashboard

Which drugs does patent 6,878,721 protect, and when does it expire?

Patent 6,878,721 protects ARCAPTA NEOHALER and UTIBRON and is included in two NDAs.

This patent has forty-three patent family members in thirty-three countries.

Summary for Patent: 6,878,721

Title:	Beta2-adrenoceptor agonists
Abstract:	Compounds of formula ##STR1## in free or salt or solvate form, where Ar is a group of formula ##STR2## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
Inventor(s):	Cuenoud; Bernard (Horsham, GB), Bruce; Ian (Horsham, GB), Fairhurst; Robin Alec (Horsham, GB), Beattie; David (Horsham, GB)
Assignee:	Novartis AG (Basel, CH)
Application Number:	10/009,008
Patent Claim Types: see list of patent claims	Compound; Composition; Use; Process;

Drugs Protected by US Patent 6,878,721

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Sunovion Pharms Inc	ARCAPTA NEOHALER	indacaterol maleate	POWDER;INHALATION	022383-001	Jul 1, 2011		RX	Yes	Yes			Y	Y		THE LONG TERM, ONCE-DAILY MAINTENANCE BRONCHODILATOR TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA
Sunovion Pharms Inc	UTIBRON	glycopyrrolate ; indacaterol maleate	POWDER;INHALATION	207930-001	Oct 29, 2015		RX	Yes	Yes			Y	Y		LONG - TERM MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Foreign Priority and PCT Information for Patent: 6,878,721

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9913083	Jun 04, 1999

PCT Information
PCT Filed	June 02, 2000	PCT Application Number:	PCT/EP00/05058
PCT Publication Date:	December 14, 2000	PCT Publication Number:	WO00/75114

Non-Orange Book US Patents Family Members for Patent 6,878,721

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,796,307	Beta2-adrenoreceptor agonists
8,067,437	Beta-2-adrenoreceptor agonists
8,283,362	Beta-2-adrenoreceptor agonists
7,622,483	.beta.2-adrenoceptor agonists

International Patents Family Members for US Patent 6,878,721

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Taiwan	I253447
Turkey	200103497
Slovakia	287260
Slovakia	17432001